Emicizumab 60mg/0.4ml solution for injection vials
NHS hospitals in England used £132,802,855 of indicative cost of Emicizumab 60mg/0.4ml solution for injection vials in the 12 months to July 2026, about 0.5% of all hospital medicines spend. That is down 7.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Emicizumab 60mg/0.4ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Emicizumab 60mg/0.4ml solution for injection vials most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £26,727,710 |
| Manchester University Nhs Ft | £21,013,110 |
| Univ Hpls Bristol Nhs Foundation Trust | £15,815,384 |
| Oxford University Hospitals Nhs Ft | £10,342,315 |
| Royal Free London Nhs Foundation Trust | £10,129,768 |
| Sheffield Teaching Hospitals Nhs Trust | £6,912,589 |
| Nottingham University Hospitals Trust | £6,202,490 |
| Leeds Teaching Hpls Nhs Trust | £4,255,759 |
| Aintree University Hospital Nhs Ft | £4,125,332 |
| University Hpls Of Leicester Nhs Trust | £4,004,567 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.